Taro to Acquire Alchemee From Galderma
23 February 2022 - 1:23AM
Business Wire
- Alchemee’s flagship brand Proactiv® is an iconic product
synonymous with acne care
Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
(“Taro”) announced today they have signed a definitive agreement
for Taro to acquire Alchemee, formerly The Proactiv Company (TPC),
from Galderma. The agreement between Galderma and Taro includes
Alchemee’s business and assets around the world, including the
Proactiv® brand.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220222005795/en/
"We are excited to add
Proactiv® to Taro’s broad portfolio of prescription and
over-the- counter dermatology products. We look forward to
welcoming the Alchemee team into Taro
and working together to continue
to make a difference to the millions of people living with acne
around the world.
UDAY BALDOTA CHIEF EXECUTIVE
OFFICER TARO
Proactiv® has been used and trusted by millions around
the world for more than 25 years. Originally set up as a
subscription-based business, Proactiv® quickly became a
leading U.S. consumer acne brand.
“We are proud of the work we have
done together to serve customers suffering from acne around the
world through Proactiv®. I am confident that Taro is the
right owner to build on Alchemee’s strong foundation. Their vision
is aligned to Alchemee, which comes with an incredible legacy and
brand equity, and a great team with a clear plan for future
success.”
FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER GALDERMA
The acquisition is subject to customary closing conditions and
any necessary regulatory approvals. Financial terms of the
transaction have not been disclosed.
About Alchemee At Alchemee, we aspire to inspire. We are
alchemists at heart, harnessing science to create powerful wellness
solutions. The combination of alchemy and “me” offers the right
mixture of science, expertise, and support that empowers our
customers with confidence. Through one-of-a-kind expert-designed
formulas and positive guidance, Alchemee provides solutions that
are as effective as they are transformative. At Alchemee, we are
committed to empowering the world one person at a time. Alchemee.
Transformation beyond expectation. www.alchemee.com
About Galderma Galderma is the world’s largest
independent dermatology company, present in approximately 100
countries. Since our inception in 1981, we have been driven by a
complete dedication to dermatology. We deliver an innovative,
science-based portfolio of sophisticated brands and services across
Aesthetics, Consumer Care and Prescription Medicine. Focused on the
needs of consumers and patients, we work in partnership with
healthcare professionals to ensure superior outcomes. Because we
understand that the skin we’re in shapes our life stories, we are
advancing dermatology for every skin story. For more information:
www.galderma.com.
About Taro Taro Pharmaceutical Industries Ltd. is a
multinational, science-based pharmaceutical company, dedicated to
meeting the needs of its customers through the discovery,
development, manufacturing and marketing of the highest quality
healthcare products. For further information on Taro Pharmaceutical
Industries Ltd., please visit the Company’s website at
www.taro.com.
Forward-Looking Statements
Some of the information contained in this press release may
contain forward-looking statements. Readers are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual
results may differ materially from those in the forward-looking
statements as a result of various factors. Neither Galderma,
Alchemee, nor Taro has any obligation to publicly update or revise
any forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220222005795/en/
Media Contact Galderma Christian Marcoux, M.Sc.
Chief Communications Officer christian.marcoux@galderma.com +41 76
315 26 50
Sébastien Cros Director, Global Communications
sebastien.cros@galderma.com +41 79 529 59 85
Taro William J. Coote VP, Chief Financial Officer (914)
345-9001 William.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Apr 2024 to May 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From May 2023 to May 2024